2 No-Brainer High-Yield Stocks to Buy With $100 Right Now — Positive

ENB  EPD   The Motley Fool — February 14, 2025

If you have $100 and are looking to generate some long-term income from an investment, you don't have to settle for the 1.2% yield on offer from the S&P 500 index. You can do much better than that without taking on a huge amount of business risk.

image for news 2 No-Brainer High-Yield Stocks to Buy With $100 Right Now

Rob Arnott on the Upside of Getting Dumped This Valentine's Day — Neutral

NIXT   ETF Trends — February 14, 2025

It's Valentine's Day, and if Rob Arnott has it his way, we will all be celebrating the upside of getting dumped. The founder of Research Affiliates, one of the great minds in the world of index investing, has a flair for colorful language.

image for news Rob Arnott on the Upside of Getting Dumped This Valentine's Day

DexCom Stock Rises Despite Q4 Earnings Miss & Lower Margins — Positive

DXCM   Zacks Investment Research — February 14, 2025

DXCM's fourth-quarter 2024 earnings decline despite increasing sales. Its performance in 2025 is expected to be fueled by global growth in CGM adoption, strong Sensor sales and expansion into new markets.

image for news DexCom Stock Rises Despite Q4 Earnings Miss & Lower Margins

Why Structure Therapeutics Stock Was Stumbling This Week — Negative

GPCR   The Motley Fool — February 14, 2025

The past few days haven't been kind to most stocks in the white-hot obesity drugs space. One developer of a weight loss medication, clinical-stage biotech Structure Therapeutics (GPCR 0.16%), was a victim of a general rout in the segment.

image for news Why Structure Therapeutics Stock Was Stumbling This Week

Oil prices on track for weekly gain as tariff fears fade — Positive

BNO  DBO  GUSH  IEO  OIH  OIL  PXJ  UCO  USO  XOP   Market Watch — February 14, 2025

Oil futures rose Friday and were on track to snap a streak of three straight weekly losses, finding support after President Trump didn't immediately impose reciprocal tariffs on U.S. trading partners.

image for news Oil prices on track for weekly gain as tariff fears fade

Here's Why Hold Strategy is Apt for ConocoPhillips Stock Now — Neutral

COP   Zacks Investment Research — February 14, 2025

Favorable oil prices are aiding COP's bottom line. However, the stock is exposed to commodity price volatility.

image for news Here's Why Hold Strategy is Apt for ConocoPhillips Stock Now

Twilio Stock Falls 7% on Q4 Earnings Miss and Dull Q1 EPS Guidance — Neutral

TWLO   Zacks Investment Research — February 14, 2025

TWLO's fourth-quarter 2024 results reflect the benefit of growth in communications revenues and improved cost discipline.

image for news Twilio Stock Falls 7% on Q4 Earnings Miss and Dull Q1 EPS Guidance

PBF Energy's Q4 Earnings Lag Estimates, Revenues Fall Y/Y — Negative

PBF   Zacks Investment Research — February 14, 2025

PBF Q4 earnings suffer due to lower throughput volumes and a fall in refining margins. However, this is partially offset by reduced costs and expenses.

image for news PBF Energy's Q4 Earnings Lag Estimates, Revenues Fall Y/Y

TC Energy files 2024 annual disclosure documents — Neutral

TRP   GlobeNewsWire — February 14, 2025

CALGARY, Alberta, Feb. 14, 2025 (GLOBE NEWSWIRE) -- News Release – TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or the Company) has today filed with Canadian securities authorities:

image for news TC Energy files 2024 annual disclosure documents

Datadog Is in the Doghouse, But This Dip Spells Opportunity — Positive

DDOG   MarketBeat — February 14, 2025

Datadog NASDAQ: DDOG is in the doghouse following its FQ4 2024 earnings release, but this pullback is an opportunity to buy a great stock at a discounted price. The pullback was caused by tepid guidance, but guidance is in the eye of the beholder.

image for news Datadog Is in the Doghouse, But This Dip Spells Opportunity

Doximity Momentum, Big Money Support Stays Strong — Positive

DOCS   FXEmpire — February 14, 2025

Shares of Doximity, Inc. (DOCS) jump on business growth, investor inflows.

image for news Doximity Momentum, Big Money Support Stays Strong

Nvidia cuts stake in Arm Holdings, invests in China's WeRide — Neutral

ARM  NVDA  WRD   Reuters — February 14, 2025

Nvidia reduced its stake in British chip firm Arm Holdings by about 44% and exited its holdings in Serve Robotics and SoundHound AI in the fourth quarter, a regulatory filing showed on Friday.

image for news Nvidia cuts stake in Arm Holdings, invests in China's WeRide

AGCO's 2025 Outlook: Is A Turnaround On The Horizon? — Neutral

AGCO   Seeking Alpha — February 14, 2025

AGCO recently reported Q4 and FY24 earnings. While it was given for granted that last year's performance would have been poor, all eyes were on the 2025 outlook AGCO released. In this article, we analyze what should be down the road for the owner of the Fendt brand and what the current valuation of the stock suggests.

image for news AGCO's 2025 Outlook: Is A Turnaround On The Horizon?

Yelp Stock Gains as Q4 Earnings and Revenues Beat Estimates — Positive

YELP   Zacks Investment Research — February 14, 2025

While a rise in ad clicks boosts YELP's Q4 revenues, a decline in total costs and expenses drives earnings per share.

image for news Yelp Stock Gains as Q4 Earnings and Revenues Beat Estimates

5 Things to Know Before the Stock Market Opens — Negative

ABNB   Investopedia — February 14, 2025

Stock futures were ricking lower in premarket trading Friday as investors readied for economic data releases and evaluated the latest tariff proposals.

image for news 5 Things to Know Before the Stock Market Opens

NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your Pacira BioSciences, Inc. (NASDAQ:PCRX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pacira-biosciences-inc-lawsuit-submission-form?prid=129491&wire=1 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Notifies Shareholders of Pacira BioSciences, Inc.(PCRX) of a Class Action Lawsuit and an Upcoming Deadline

What's a Good Price to Buy Hershey Stock? — Negative

HSY   The Motley Fool — February 14, 2025

The Hershey Company (HSY 1.73%) is one of the less volatile businesses you can own.

image for news What's a Good Price to Buy Hershey Stock?

Better Growth Stock to Buy: Netflix vs. Spotify — Neutral

NFLX  SPOT   The Motley Fool — February 14, 2025

Netflix (NFLX 1.59%) and Spotify (SPOT 1.21%) are pioneering companies in their respective categories.

image for news Better Growth Stock to Buy: Netflix vs. Spotify

Novo Nordisk Beat Expectations in Q4 and a Huge Catalyst Could Be Coming Soon — Positive

NVO   The Motley Fool — February 14, 2025

In the GLP-1 weight loss market, it's largely been a two-horse race between Eli Lilly and Novo Nordisk (NVO -3.62%). The two companies have approved weight loss drugs that are generating billions in revenue, and there's still much more growth on the horizon.

image for news Novo Nordisk Beat Expectations in Q4 and a Huge Catalyst Could Be Coming Soon

ROCHESTER, N.H.--(BUSINESS WIRE)--Albany International Italia Srl, an affiliate of Albany International Corp. (NYSE:AIN), announced today that it will initiate consultations with employee representatives regarding the decision to discontinue manufacturing operations at a leased facility in Ballo, Italy, and to transfer production to a facility in Merone, Italy owned by Industrie Tessili Bresciane Srl, a separate affiliate of Albany International Corp. The action is subject to local law and will.

image for news Albany International Corp. Announces Plans to Consolidate Manufacturing Capacity in Italy